Rationale of a phase III study comparing a standard cisplatin regimen (mitomycin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer

被引：0
|
作者：
Tonato, M
Crino, L
Mosconi, AM
机构：
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 03期
关键词：
RANDOMIZED TRIAL; ACTIVE REGIMENS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：831 / 835
页数：5
相关论文
共 50 条
  • [1] Randomized phase III study of Gemcitabine/cisplatin versus mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer (NSCLC)
    Scagliotti, G
    Crino, L
    Conte, PF
    Rinaldi, M
    De Marinis, F
    Gridelli, C
    ANNALS OF ONCOLOGY, 1998, 9 : 85 - 85
  • [2] Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: An implementation study
    Meert, A
    Berghmans, T
    Ninane, V
    Sculier, J
    LUNG CANCER, 2005, 49 : S258 - S258
  • [3] Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer:: A randomized phase III study of the Italian lung cancer project
    Crinò, L
    Scagliotti, GV
    Ricci, S
    De Marinis, F
    Rinaldi, M
    Gridelli, C
    Ceribelli, A
    Bianco, R
    Marangolo, M
    Di Costanzo, F
    Sassi, M
    Barni, S
    Ravaioli, A
    Adamo, V
    Portalone, L
    Cruciani, G
    Masotti, A
    Ferrara, G
    Gozzelino, F
    Tonato, M
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 3522 - 3530
  • [4] Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients
    Cok, Gursel
    Goksel, Tuncay
    Soyer, Serdar
    Atil, Hulya
    Guzelant, Asuman
    Aysan, Tulin
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2006, 54 (02): : 161 - 167
  • [5] MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN NON-SMALL CELL LUNG-CANCER
    CULLEN, MH
    CHETIYAWARDANA, AD
    JOSHI, R
    WOODROFFE, CM
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 893 - 893
  • [6] MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN NON-SMALL CELL LUNG-CANCER
    CULLEN, MH
    CHETIYAWARDANA, AD
    JOSHI, R
    WOODROFFE, CM
    BRITISH JOURNAL OF CANCER, 1988, 58 (02) : 259 - 259
  • [7] Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer
    Chen, YM
    Perng, RP
    Whang-Peng, J
    Wu, HW
    Lin, WC
    Tsai, CM
    LUNG CANCER, 2000, 30 (03) : 199 - 202
  • [8] Phase II study of regimen of gemcitabine and cisplatin in advanced non-small cell lung cancer
    Chen, SCH
    Lin, MC
    Chang, JWC
    Wang, SW
    Lee, CH
    Tsao, TCY
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (11) : 494 - 498
  • [9] Phase II study of Gemcitabine in combination with cisplatin and ifosfamide in advanced non-small cell lung cancer
    Mohedano, N
    Medina, MB
    Sanchez, P
    Jaen, A
    Gonzalez, E
    Porras, I
    Fernandez, M
    Lozano, A
    ANNALS OF ONCOLOGY, 1998, 9 : 90 - 90
  • [10] Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer
    Sacristán, JA
    Kennedy-Martin, T
    Rosell, R
    Cardenal, F
    Antón, A
    Lomas, M
    Alberola, V
    Massuti, B
    Carrato, A
    Minshall, M
    LUNG CANCER, 2000, 28 (02) : 97 - 107
12345